Immutep Ltd IMM.AX :
* IMMUTEP'S CHINESE PARTNER EOC PHARMA TO START PHASE II METASTATIC BREAST CANCER STUDY
* IMMUTEP LTD - NEW RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL STUDY TO COMMENCE IN Q1 CY2021
* IMMUTEP LTD - FULLY FUNDED BY EOC PHARMA, TRIAL WILL INVOLVE APPROX. 152 PATIENTS ACROSS 20 CLINICAL TRIAL SITES IN CHINA